Characterization of common marmoset dysgerminoma‐like tumor induced by the lentiviral expression of reprogramming factors
Authors:
Open Access
- 12 February 2014
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 105 (4) , 402-408
Abstract
Recent generation of induced pluripotent stem (iPSCs) has made a significant impact on the field of human regenerative medicine. Prior to the clinical application of iPSCs, testing of their safety and usefulness must be carried out using reliable animal models of various diseases. In order to generate iPSCs from common marmoset (CM; Callithrix jacchus), one of the most useful experimental animals, we have lentivirally transduced reprogramming factors, including POU5F1 (also known as OCT3/4), SOX2, KLF4, and c‐MYC into CM fibroblasts. The cells formed round colonies expressing embryonic stem cell markers, however, they showed an abnormal karyotype denoted as 46, X, del(4q), +mar, and formed human dysgerminoma‐like tumors in SCID mice, indicating that the transduction of reprogramming factors caused unexpected tumorigenesis of CM cells. Moreover, CM dysgerminoma‐like tumors were highly sensitive to DNA‐damaging agents, irradiation, and fibroblast growth factor receptor inhibitor, and their growth was dependent on c‐MYC expression. These results indicate that DNA‐damaging agents, irradiation, fibroblast growth factor receptor inhibitor, and c‐MYC‐targeted therapies might represent effective treatment strategies for unexpected tumors in patients receiving iPSC‐based therapy.Keywords
This publication has 26 references indexed in Scilit:
- Inhibition of PTEN Tumor Suppressor Promotes the Generation of Induced Pluripotent Stem CellsMolecular Therapy, 2013
- Human-Induced Pluripotent Stem Cells: In Quest of Clinical ApplicationsMolecular Biotechnology, 2012
- Induced pluripotent stem cells: opportunities and challengesPhilosophical Transactions of the Royal Society B: Biological Sciences, 2011
- Cancer-Related Epigenome Changes Associated with Reprogramming to Induced Pluripotent Stem CellsCancer Research, 2010
- A chemical platform for improved induction of human iPSCsNature Methods, 2009
- Embryonic stem cell–specific microRNAs promote induced pluripotencyNature Biotechnology, 2009
- Generation of induced pluripotent stem cells without Myc from mouse and human fibroblastsNature Biotechnology, 2007
- Generation of germline-competent induced pluripotent stem cellsNature, 2007
- Specification of motoneurons from human embryonic stem cellsNature Biotechnology, 2005
- A study of ovarian dysgerminoma with emphasis on the role of radiation therapy.1961